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ABSTRACT 
This case of refractory schizophrenia in a 28 year old male showed significant improvement 
with clozapine. But therapeutic doses of clozapine were associated with generalised tonic clonic 
seizures (GTCS). Addition of sodium valproate allowed adequate control of schizophrenic symp-
toms as well as seizures. EEG abnormality correlated surprisingly well with development ofGTCS 
and subsequent improvement with anticonvulsant. Factors that lead to seizure-vulnerability in 
clozapine treated patients are discussed. 
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Clozapine's haematological side effects 
have received much attention, but seizures 
constitute another major complication of 
therapy. Recent studies indicate that the previ-
ous incidence of 3-5% may have been an un-
derestimation. One such study reports a cumu-
lative risk of 10% after 3.8 years of treatment 
(Devinsky & Pacia, 1994). The seizure types 
reported are generalised tonic clonic convul-
sions, myoclonic and absence seizures, com-
plex partial seizures, absence status (Freedman 
et al., 1994), cataplexy like attacks and subtle 
myoclonic movements. In a report by Welch & 
colleagues, 5 of their first thirty-five patients de-
veloped tonic clonic convulsions, 3 had myo-
clonic seizures, and 2 suffered from complex 
partial seizures (Welch et al., 1994). 
In our experience in a tertiary referral 
centre, seizures have been a fairly common 
complication of clozapine therapy. 
CASE REPORT 
Mr. S, a 28 year old single male has been 
suffering from a continuous illness of 10 years 
characterised by reduced social interaction, 
hearing voices of unseen men commenting on 
his thought and behaviour, suspecting family 
members of planning to kill him. He believed 
he was born to become a big filmstar and that 
some aliens had attached instruments in brain 
and genitals to control his actions and thoughts. 
He also complained that his neighbours always 
talked about him and ridiculed him. His personal 
upkeep remained poor, and he never took up 
his studies or any employment. He would sud-
denly turn violent on minor provocation. His 
aggressive outbursts were purposive, lasted 
1-2 days and there was nd history suggestive 
of automatism during these periods. During one 
of his numerous episodes of violence, his 
mother sustained multiple fractures and other 
injuries. 
There was no history suggestive of 
prominent mood symptoms, substance use or 
a general medical condition. Family history of 
a single episode excitatory psychosis was 
present in a cousin, for which no details were 
available. 
Mental status examination on admission 
(1991) and serial examination conducted 
thereafter revealed thought broadcasting, 
delusion of reference, bizarre delusion, made 
act, second and third person auditory halluci-
nations which were mostly imperative, and 
visual and olfactory hallucinations. Affect and 
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TABLE 
TREATMENT PRIOR TO INTRODUCTION OF CLOZAPINE 
Drug 
Haloperidol (O) 
Tnrlouperazme (O) 
Fiupenthixpl {O) 
Chlorpromazine (O) 
Fluphenazine (1) 
Diazepam (O) 
•Imipramine (0) 
"Clomipramine (O) 
ECT 
Maxm. dose 
30 mg/day 
25 mg/day 
39 mg/day 
300 mg/day 
50 mg/day 
185 mg/day 
125 mg/day 
75 mg/day 
12 such 
Period of administration 
Oct. '91-Dec.'91 
Dec. 91-Jun. '92, Aug. '92-Jun.'93 
June '92-Aug.92 
Jun. ' 93-Oct. '93 
Nov. '91-Mar/96 
Apr. '92-Mar. '96 
Jan. 92-Feb. '92 
Mar. '95-Mar. "96 
Feb. '92 
0 - oral 
1 - injection 
•for negative symptoms 
** for compulsive washing. Our patient developed compulsive hand-washing around March 1995, for which clomipramine 
was added on to his antipsychotic regime. Within a few months of this addition, his compulsive symptoms disappeared 
completely. Later, clomipramine (and also the antipsychotic he was receiving at that point of time) was discontinued in March 
1996 in view of starting clozapine therapy Thus the compulsive symptoms had disappeared about eight months before 
clozapine was started and never appeared again. 
higher cognitive functions were preserved. 
Findings of an initial neurological 
examination had been unremarkable, However, 
the neurological examination conducted in Sep-
tember 1996, about 10 years after the onset of 
illness, showed impaired two point discrimina-
tion, clumsier finger-nose test on left side, im-
paired planning, and stimulus boundedness ; 
all suggesting a probable fronto-parietal 
deficit. 
In the hospital (since 1991) he received 
adequate trials of conventional antipsychotics 
of different classes, augmented with high dose 
benzodiazepines and ECT (for details, vide 
table 1), but these did not significantly improve 
his psychopathology. A higher than usual dose 
of neuroleptics could not be given for 
disturbing akathisia and pseudoparkinsonism. 
He remained deluded, had disturbing auditory 
and visual hallucinations. There were 
unpredictable bouts of severe violence 
secondary to his delusions, command 
hallucination and experience of somatic 
passivity. In fact, violence was a major 
problem in the hospital and to control it 
diazepam was added. Violence was effectively 
controlled with diazepam but his psychopathol-
ogy remained untouched. 
Clozapine (325 mg/day) was started in 
March 1996 and there was notable 
improvement. He was even ready to challenge 
his previous delusional system. But 
unfortunately, he developed generalised tonic 
clonic seizures at this stage and continued to 
have them until the dose was reduced to 250 
mg/day. 
EEGs were done for this patient in 1992 
and 1994. In 1992, the EEG showed a 
predominantly beta background activity 
(probably due to benzodiazepines) and 
doubtful focal abnormal discharge in the form 
of brief runs of theta waves from bilateral 
central and occipital areas, more prominent on 
the right side.' In 1994, the only abnormality 
shown in the EEG was predominantly beta 
background which could be due to 
benzodiazepines. 
Two months after starting clozapine, how-
ever, the EEG showed a poorly organised back-
ground alpha activity with generalised 
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discharges in the form of sharp and slow waves, 
and spike and slow waves. There were 
eighteen occassions of seizure discharges, their 
duration varying from 400 milliseconds to 2 
second. 
Subsequent EEG done of 16.8.96 
revealed seizure discharges on twenty-two 
occassions, duration varying from 200 
millisecond to 2 seconds. 
As his dose of clozapine was reduced 
(250 mg/day), his psychopathology resurfaced. 
Hence it was decided to increase the dose of 
clozapine till adequate clinical response was 
achieved, under cover of an antiepileptic drug 
(sodium valproate). Since the introduction of 
sodium valproate, he has had no seizure. 
A third EEG (11.9.96), recorded after 
sodium valproate was added to the existing 
regime showed only six episodes of epileptic 
activity, lasting between 600 milliseconds to 1 
second. 
Meanwhile, as the dose of clozapine was 
increased, there was significant improvement 
in psychopathology. Currently his aggressive 
outbursts are completely under control (last 
outburst in March '96). 
DISCUSSION 
Reported risk factors for development of 
seizures during clozapine therapy include- a) 
high dose-but recent studies do not confirm this 
dose-dependant effect (Devinsky & Pacia, 
1994), and some have reported the highest risk 
between doses of 75-400 mg/day (Gunther et 
al., 1993), b) rapid upward titration of dose.c) 
polypharmacy, d) discontinuation of diazepam 
treatment (Gunther et al., 1993), e) preexisting 
structural brain damage. 
Our patient was on 325 to 375 mg/day 
of clozapine when he developed seizures; 
initiation of therapy was preceeded by a gradual 
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"Correspondence 
reduction (10 mg/week) of high dose of 
diazepam (185 mg/day). Neurological signs 
implicating his frontal and parietal lobes were 
present and EEGs prior to clozapine had shown 
bilateral episodic slowing from occipital-central 
areas, though no epileptiform activity was seen. 
All these factors could have contributed to his 
seizure susceptibility. Treatment with 
antiepileptic cover successfully controlled his 
seizures. 
There have been reports of priapism 
following combined sodium valproate and cloza-
pine therapy. Our patient did not develop any 
such side effect. 
We would also like to point out that EEG 
abnormality alone has been reported in 74% 
patients on clozapine treatment (Welch et al., 
1994). But an abnormal EEG does not always 
translate into a clinical seizure and hence, does 
not warrant antiepileptic treatment. 
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